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Abstract Fanconi’s anemia (FA) is a very rare genetically
heterogeneous disease which has been hypothesized to be
defective in the detoxification of reactive oxygen species. In this
work we report the results obtained by morphometric and
biochemical analyses on the red blood cells (RBCs) from FA
patients. With respect to RBCs from healthy donors the
following changes have been detected : (i) a variety of
ultrastructural alterations, mainly surface blebbing typical of
acanthocytes and stomatocytes; (ii) a significant quantitative
increase of these altered forms; (iii) modifications of spectrin
cytoskeleton network; (iv) an altered redox balance, e.g. a
decreased catalase activity and significant variations in the
GSSG/GSH ratio. We hypothesize that remodeling of the redox
state occurring in FA patients results in cytoskeleton-associated
alterations of red blood cell integrity and function.
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1. Introduction
Fanconi’s anemia (FA) is a rare (about 1:400 000) autoso-
mal recessive disease characterized by somatic anomalies, pan-
cytopenia, retarded development, hyperpigmentation of the
skin, propensity to developing acute leukemia and solid tu-
mors [1]. The disease is usually fatal, with a life expectancy of
approximately 16 years.
In FA patients, typical signs of anemia were found and
studied since 1927 [2]. Considering that the oxidative imbal-
ance is involved in determining cell aging and cell death [3]
and that oxidative stress could be considered as a phenotypic
hallmark of Fanconi’s anaemia (reviewed by Pagano et al.
[4]), the possible role of a redox alteration, resulting in red
blood cell loss, can be taken into account. In particular, as a
general rule, an excess formation of reactive oxygen species
(ROS) and/or an impairment in the activity of antioxidant
enzymes causing severe subcellular oxidative lesions was hy-
pothesized [5]. Thus, in order to investigate red blood cell
(RBC) loss detected in Fanconi’s congenital disorder, eryth-
rocytes from FA patients with cytogenetically con¢rmed diag-
nosis were isolated and examined by means of morphometric
and biochemical analyses. Particular emphasis was given to
the redox alterations and to oxidative changes occurring in
RBC cytoskeletal components.
2. Materials and methods
2.1. Patients and blood drawing
FA patients have been recruited from di¡erent parts of Italy and
examined at the Hematological Department of the St. Eugenio Hos-
pital, Tor Vergata University (Rome, Italy) after their informed con-
sent. The group of FA patients studied (12 patients for biochemical
analyses and, among them, seven for morphometric analyses, aged 3^
15 years) exhibited symptoms of prolonged anemia. The FA diagnosis
(complementation group A) was con¢rmed clinically and cytogeneti-
cally [6]. As control, six healthy members of our laboratory sta¡ and
14 healthy children (aged 8^15 years) were used after their or their
relatives’ informed consent. Venous blood was obtained by venipunc-
ture using Becton-Dickinson (Rutherford, USA) heparinized vacu-
tainers (10 ml) in the morning before any food.
2.2. Erythrocyte isolation
Human erythrocyte suspensions were prepared from fresh venous
blood collected into heparinized tubes and centrifuged for 10 min at
1500Ug. The plasma and bu¡y coat were then removed. The red cell
preparations were washed two times in Bu¡er G (50 mM Tris, 50 mM
HEPES, 10 mM MgCl2, 2 mM EDTA, 10 mM D-glucose, 10 mM
CaCl2, 50 mM NaCl, 5 mM KCl and 0.1% bovine serum) and resus-
pended in the same bu¡er to the initial hematocrit concentration. No
appreciable cell lysis was observed during the preparation procedure.
2.3. Scanning electron microscopy (SEM) and morphometry
Control erythrocytes and those from FA patients were ¢xed with
2.5% glutaraldehyde in 0.1 M cacodylate bu¡er (pH 7.4) at room
temperature for 20 min, seeded on glass coverslips coated with poly-
lysine and, after adhesion to the glass surface (about 10 min), post-
¢xed in 1% osmium tetroxide for 30 min. These blood cells were then
dehydrated through graded ethanols, critical point dried in CO2 and
gold coated by sputtering. The samples were examined with a Cam-
bridge 360 scanning electron microscope. Altered erythrocyte shape
was evaluated by counting at least 500 cells (50 erythrocytes for each
SEM ¢eld at a magni¢cation of 3000U) of healthy individuals and
FA patients in triplicate.
2.4. Cytoskeletal analyses
Erythrocytes from healthy donors and those from FA patients were
¢xed with 3.7% formaldehyde in PBS (pH 7.4) for 10 min at room
temperature and after washing in the same bu¡er, were permeabilized
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with 0.5% Triton X-100 (Sigma) in PBS for 5 min also at room
temperature. The erythrocytes were then stained with anti-spectrin
(Sigma) at 37‡C for 30 min and subsequently incubated with anti-
rabbit IgG-£uorescein linked whole antibody (Sigma) at 37‡C for 30
min. Finally, after washing, all the samples were mounted with glyc-
erol-PBS (2:1) and observed with a Nikon Microphot £uorescence
microscope or by a confocal microscope.
2.5. Redox analyses
To determine reduced and oxidized glutathione (GSH/GSSG) con-
tent and activity of enzyme with antioxidant properties as CuZnSOD
and catalase, the washed erythrocytes were lysed by hypotonic shock
with distilled water and 0.1 ml of hemolysate was mixed with 0.7 ml
cold water, 0.2 ml ethanol and 0.1 ml chloroform. The mixture was
shaken vigorously for 3^5 min and centrifuged at 3000Ug for 10 min.
The clear top layer possessing SOD and catalase activities was frozen
immediately at 320‡C until analyses.
The CuZnSOD activity was determined by the inhibition of super-
oxide-mediated lucigenin-ampli¢ed chemiluminescence produced dur-
ing the xanthine oxidation by xanthine oxidase [7]. Catalase activity
was determined by Aebi method [8]. Reduced glutathione (GSH) con-
centration was measured in the erythrocyte sediment according to
Hughes by evaluating the reduction of 5,5P-dithiobis(2-nitrobenzoic
acid) (DTNB) by sulfhydryl compounds at 412 nm. The levels of
oxidized glutathione (GSSG) in the cell extracts were determined as
stated elsewhere [9] in the presence of glutathione reductase to prevent
additional GSH oxidation. The activity of erythrocyte antioxidant
enzymes were expressed as units of enzyme per gram of protein.
The protein content in the ethanol^chloroform extract was determined
by the Lowry method [10] using a protein kit. The zinc content in
erythrocytes was determined by atomic absorption spectroscopy [11].
Superoxide generation by erythrocytes was measured using SOD-
sensitive cytochrome c reduction. Erythrocyte samples were incubated
at 37‡C for 1 h with 50 mM cytochrome c with or without 10 mg/ml
of bovine SOD. Then, erythrocytes were sedimented by centrifugation
at 1500Ug for 5 min and light absorbance of clear supernatant was
measured at 550 nm (Beckman DU 600 spectrophotometer). Each
sample was incubated and measured in duplicate, the variation coef-
¢cient between duplicates did not exceed 10%. Reagent mixture with-
out red cells was used as blank. The spontaneous superoxide release
from erythrocytes was calculated as the di¡erence between absorban-
ces in the absence and presence of exogenous SOD using the
OM = 21p 000 for reduced cytochrome c. The results were expressed
in nmol/60 min/ml 1010 RBC.
2.6. Lipid analyses
The extracts for lipid analyses were prepared with 0.5 ml of packed
erythrocytes. These were hemolyzed for 15 min with an equal volume
of water, then 11 ml of isopropanol was added slowly while stirring,
as well as 7 ml of chloroform. The lipid extracts, ¢ltered on anhydrous
sodium sulfate and dried under nitrogen, were used for the analytical
determination. The fatty acid pattern of erythrocyte membrane lipids
was determined by gas-chromatographic analysis of fatty acid methyl
esters as described previously [12].
2.7. Chemicals
The following reagents were purchased from Sigma (St. Louis, MO,
USA): lucigenin, diepoxybutane, xanthine, xanthine oxidase, potassi-
um phosphate bu¡er (PBS), cytochrome c (type VIII), DTNB, metri-
zoate, reduced and oxidized glutathione, glutathione reductase, bovine
erythrocyte SOD (EC 1.15.1.1) and catalase (EC 1.11.1.6). Hydrogen
peroxide was from Merck (Darmstadt, Germany). It was titrated with
KMnO4.
2.8. Statistical analysis
Data are reported as means þ S.D. for each group examined. The
comparison between variables was analyzed by Student’s t-test. Sig-
ni¢cance was accepted at the P6 0.05 level.
3. Results
3.1. Analytical cytology. Qualitative studies
In order to determine whether erythrocytes from FA pa-
tients di¡er in surface morphology from the RBC of healthy
donors, qualitative SEM analyses were ¢rst conducted. As
shown in Fig. 1, the surface of the red blood cells isolated
from the patients was greatly altered with respect to control
erythrocytes. In particular, surface blebbing typical of acan-
thocytes (Fig. 1b) and rare stomatocytes (Fig. 1c,d) were ob-
served. Moreover, other shrunk forms, e.g. of leptocytic mor-
phology, were also found (Fig. 1d).
3.2. Quantitative analyses
Studies were then carried out in order to evaluate statistical
signi¢cance of these ¢ndings. Morphometric analyses were
thus performed considering the alterations observed in the
erythrocytes of each FA patient as speci¢ed in Section 2.
RBCs from healthy donors were considered as control. Di¡er-
ent values found in each FA patient are reported in Fig. 2.
Morphometric analyses clearly indicate a variable and re-
markable percentage of altered RBCs from seven di¡erent
FA patients with respect to that found in control samples.
In particular, the mean percentage of altered red blood cells
in the FA patient group was of 42.8 þ 4.9% while that found
in the control group was 15.0 þ 4.7% (P6 0.01).
3.3. Cytoskeletal analyses
Because of the importance of cytoskeleton in cell shape
maintenance and in surface bleb formation [13], experiments
were also conducted in order to learn whether the micro¢la-
ment network could be altered. The cytoskeleton network
formed by spectrin molecules appeared peculiarly modi¢ed
in the erythrocytes from FA patients (Fig. 3b) with respect
to the RBC of healthy donors (Fig. 3a). A subtle spectrin
boundary network was visible in RBCs from control subjects
(Fig. 3a). By contrast, signi¢cant changes were found in RBCs
from FA patients: a patching, or a side by side bundling and
cross linking of spectrin ¢laments, which appeared as thick
positive ¢bers, was detected (Fig. 3b).
Fig. 1. Scanning electron microscopy. In panel (a) erythrocytes from
healthy donors can be observed. By using this technical approach
these cells appear as typical biconcave discs. By contrast, erythro-
cytes from FA patients show di¡erent types of alterations: surface
blebbing typical of acanthocytes (b); rare swollen RBCs and stoma-
tocytes (c and d) and shrunk forms of leptocytic morphology (d).
Magni¢cation 1680U.
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3.4. Biochemical analyses
It was observed that the mean value of SOD activity in FA
patients was signi¢cantly lower (344%, P6 0.05) than in
healthy donors. No di¡erence in zinc content and superoxide
release was detected between the studied groups. The mean
value of catalase activity was also signi¢cantly decreased
(377%, P6 0.05) in the RBCs of patients compared to con-
trol values. Evaluation of intracellular thiol pools indicated
signi¢cant variations. In fact, the GSH level in erythrocytes
from FA patients was increased and, more important, the
GSSG/GSH ratio was twice as high in FA patients as com-
pared to the control RBCs (P6 0.01). The polyunsaturated
fatty acid (PUFA) composition of erythrocyte membrane lip-
ids, considered as a substrate of oxygen radical attack, was
also studied by gas-chromatographic analysis. However, no
signi¢cant di¡erence both in fatty acid composition and in
PUFA content was found in control samples (29.2 þ 2.0)
and in RBCs from FA patients (33.0 þ 2.5) (Table 1).
4. Discussion
It has been suggested that disorders of the erythrocyte
membrane, such as hereditary spherocytosis, hereditary ellip-
tocytosis and hereditary poikilocytosis, are characterized by
heterogeneity in their clinical and laboratory manifestations
but they share, as common feature, alterations of RBC de-
formability and plasticity, usually associated with cytoskele-
ton changes [14,15]. These changes are strictly related to those
alterations of morphological and rheological properties of cir-
culating erythrocytes which can be detected either in the aging
process or in some pathologic conditions including FA [17^
19]. A possible general role exerted by redox alterations in
these modi¢cations has also been proposed [4,16]. In fact, in
the present work we show that RBCs from FA patients are
signi¢cantly modi¢ed by a mechanism involving cytoskeleton
integrity and we also hypothesize a role for redox imbalance
in these changes. An extensive body of evidence has associated
the FA phenotype with the occurrence of oxidative stress
[4,20]. For instance, it has been shown that FA ¢broblasts
and leukocytes exhibited lower than normal levels of SOD
and/or catalase activities [21]. Our results support these ¢nd-
ings indicating that erythrocytes from FA homozygotes pos-
sess a signi¢cantly decreased activity of above enzymes. At the
same time, the ratio GSSG/GSH was signi¢cantly higher in
Fig. 2. Percentages of altered erythrocytes evaluated in seven di¡er-
ent subjects with FA (FA, MA, PS, VM, GA, DS, GG) compared
to healthy donors. For each patient the values are expressed as
mean þ S.D. of di¡erent samples evaluated as stated in Section 2.
Healthy donors are pooled together and only the mean value þ S.D.
is shown.
Fig. 3. Immuno£uorescence microscopy. Spectrin labeling. a: Eryth-
rocytes from healthy donors. A thin boundary spectrin positive ¢la-
ment network is visible. b: Erythrocytes from FA patients. Spectrin
cytoskeleton appears rearranged forming patches and cross-links. In
particular, a side by side bundling of spectrin ¢laments is evident.
Magni¢cation 1400U.
Table 1
Controls FA patients
Superoxide release (nmol/60 minUml 1010 RBC) 76 þ 31 146 þ 135
SOD* (mU/mg protein) 24.8 þ 5.3 14.1 þ 3.5
Catalase* (mU/mg protein) 362 þ 42 83.6 þ 23.5
Zinc (ppm) 33.7 þ 17.2 35.4 þ 7.8
GSH* (Wmol/g Hb) 6.6 þ 1.0 7.8 þ 0.2
GSSG/GSH** 1.8 þ 0.6 3.6 þ 1.7
*P6 0.05; **P6 0.01.
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the FA patients in comparison with that found in the control
group. This fact points to the excess amount of oxidized glu-
tathione in FA erythrocytes that could be a consequence of
hyperoxidation of GSH.
The cytoskeleton was largely described as a subcellular
structure involved in oxidative modi¢cations leading to cell
injury [13,15]. In this context, the results reported in this
work represent the ¢rst evidence for cytoskeleton changes
occurring in RBCs from FA patients and suggest a possible
role for actin binding proteins, e.g. spectrin, in altered RBC
function in this disease. In fact, £uorescent labeling of spectrin
molecules with speci¢c antibodies employed in order to assess
the integrity of spectrin^actin junction sites, known to be re-
sponsible for the red cell deformability and shape mainte-
nance [22,23], clearly indicated a profound alteration of the
micro¢lament system network. Thus, signi¢cant alterations of
RBC shape, mainly represented by cell swelling, blebbing and/
or shrinking, have been detected. These data are suggestive for
a speci¢c ‘chronic’ oxidative modi¢cation, denaturation and
crosslinking (or defective bundling) of cytoskeletal compo-
nents in RBCs from these subjects. This should result in a
decreased deformation ability (or an increased rigidity).
In conclusion, the present study corroborates the evidence
for the occurrence of oxidative damage in FA (or at least
FAA) phenotype. This evidence is both substantiated by the
observed alterations in RBC cytoskeleton and by the reduced
antioxidant, e.g. catalase, activity. Thus, it can be suggested
that the FA phenotype can be included among those congen-
ital conditions sharing oxidative stress as a phenotypic hall-
mark [4,24]. In particular, the multifaceted damage which is
detectable in FA patients seem to indicate the erythrocyte
integrity, its cytoskeleton and the redox state of these cells
as an important tool in the diagnostic characterization of
this rare disease. These features may also contribute to the
understanding of the functional defects observed in FA dis-
ease progression.
Altogether the data reported here partially address the
mechanisms underlying the pathogenesis of the anemia at
least in terms of RBC aging process, add some new insight
in the ¢eld of FA as a cytoskeleton-associated pathology and
suggest, according to literature data [25], the possible use of
speci¢c antioxidants and/or radical scavengers in the manage-
ment of Fanconi’s anemia.
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